CN104043042A - Traditional Chinese medicine composition for treating hepatic calculus - Google Patents
Traditional Chinese medicine composition for treating hepatic calculus Download PDFInfo
- Publication number
- CN104043042A CN104043042A CN201410272554.7A CN201410272554A CN104043042A CN 104043042 A CN104043042 A CN 104043042A CN 201410272554 A CN201410272554 A CN 201410272554A CN 104043042 A CN104043042 A CN 104043042A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of medicines, and relates to a traditional Chinese medicine composition for treating hepatic calculus. The traditional Chinese medicine composition is prepared from the following raw materials: herba artemisiae capillaris, rhizoma alismatis, radix bupleuri, rhizoma coptidis, ligusticum wallichii, angelica sinensis, radix curcumae, radix paeoniae rubra, radix salviae miltiorrhizae, radix scutellariae, endothelium corneum gigeriae galli, honeysuckle flowers, pangolin, rhizoma corydalis, liquorice and longhairy antenoron herb. The traditional Chinese medicine composition disclosed by the invention has the advantages of outstanding analgesic activity, litholytic and lithagogue effect, outstanding treatment effect, safety, reliability and wide clinical application prospect.
Description
Technical field
The invention belongs to medical technical field, relate to a kind of Chinese medicine composition and medical usage thereof for the treatment of liver and bile stone.
Background technology
Cholelithiasis is the commonly encountered diseases of biliary system, accounts for the 20%-30% of Surgical Acute Venter Diseases.In recent years, since the application clinically such as day by day perfect along with the raising of living standards of the people and inspection method, particularly B type are ultrasonic, CT, the diagnosis to biliary tract and treatment means, all provide accurate and effective therapeutic scheme.Epidemiological study shows, formation and the variation of diet composition to calculus occupies very important position.Report at the beginning of the 30's ends of China's cholelithiasis to the 60's is taking bile pigment calculus as main, especially in rural area.But national cholelithiasis analyzing specimen showed that China's cholelithiasis type had a very large change in recent years, and the ratio of cholesterol calculus has exceeded bile pigment calculus, and this is relevant with the variation of China people dietary structure.Meanwhile, in zoopery, also prove fat content in keeping on a diet or the relative scale of fatty acid and protein, can exert an influence to the quantity of calculus and composition.To the understanding of cholelithiasis, since oneth century of past, all concentrate on the various variations that extrahepatic biliary passages part occurs, think that extrahepatic biliary passages is the place that produces calculus.But after having had " causing stone sexually transmitted disease (STD) reason bile " this concept, especially while finding that extrahepatic biliary passages pathological changes still exists sending out again of pathology bile and calculus after Surgery Treatment, people turn in liver gradually to the understanding of cholelithiasis, thinking that the effect that is liver by enzyme or metabolic deficiency produce causes stone sexually transmitted disease (STD) reason bile, thereby forms calculus.
Many clinical datas show that cholelithiasis is a kind of disease relevant with liver in recent years, and cholelithiasis patient has liver disease damage to a certain degree.These results of study, rule together with Chinese traditional treatment cholelithiasis liver and gall, the liver spleen theory of ruling together has play the same tune on different musical instruments wonderful.Motherland's medical science is thought the gallbladder being attached to the liver, and liver and gall are the exterior and the interior each other, and gallbladder is the fu-organ that contains refined juice, built-in refined juice, and bile derives from gas after liver.Liver department catharsis function, dredges function of gallbladder promoting juice, and all logical factors of falling function of catharsis, courage that affects liver all can cause cholestasis, decoct with the passing of time, and bile deposits and formation sandstone.Liver controlling conveyance and dispersion, The spleen has the function to transport and transform nutrients, and the transportation capabilities of spleen must be achieved under the catharsis effect of liver is coordinated.Upper work preventing diseases instead for the treatment of diseases, the disease of seeing liver, knowing the liver disease will be transmitted into the spleen, in the ban tonifying the spleen.So theory that in the treatment of cholelithiasis, the liver and gall of should applying in a flexible way are ruled together, liver spleen is ruled together, makes therapeutic effect more perfect.
Liver, cholelithiasis belong to the category of the diseases such as the traditional Chinese medical science " rib tumor " " stomachache " " stomachache ".Etiology and pathogenesis mostly is depression of liver-QI, the liver losing its smoothly moving state, the gallbladder being attached to the liver, and gallbladder loses catharsis, qi depression to blood stasis, damp and hot retardance, pents up petrochemical industry, decocts into calculus, stagnates biliary tract, and liver and gall mechanism of qi is not changed, so for suffering from.Cholecystitis belongs to the traditional Chinese medical science " gallbladder-distention " category.Main syndromes has right rib pain, bitter taste, sighing frequently, simultaneously companion feel sick, belch, abdominal distention etc., easily outbreak repeatedly, its diseased region is at gallbladder, but has substantial connection with liver.Liver and gallbladder the exterior and the interior each other, " gallbladder is fu-viscera with clear juice, hide bile and reduce to suitable to turn dredging ", bile is " borrow gas after liver, corner enters gallbladder, gathers and forms ", its function relies on the catharsis of liver, promotes again transporting and transforming function of the spleen and stomach.Feelings will is unsuccessful, surfeit is greasy, irregular diet etc. all can affect suffocating of liver and gall and transporting and transforming function of the spleen and stomach, and QI stagnation of the liver and galibladder bile excretion is not smooth, retention of damp-heat in the interior of dysfunction of the spleen in transportation, and stagnation of QI internal organs closes and causes that gallbladder internal organs mechanism of qi is logical falls the not normal cholecystitis that then becomes.Modern medicine still lacks specific medicament and desirable means to the treatment of cholecystitis.A large amount of Clinical and experimental studies show, Chinese medicine cholecystitis has greater advantage, control gallbladder mainly with soothing the liver for reaching, reason spleen be with.Traditional Chinese medical science traditional theory is thought the liver failing to maintain the normal flow of QI, and gallbladder loses logical falling, and cholestasis can cause calculus and generate; And damp and hot, the stagnation of QI, blood stasis are three principal characters of liver and bile stone disease, treatment focuses on embodiment and " leads to, falls " two words, taking depressed liver-energy dispersing and function of gallbladder promoting, heat clearing and blood stasis dispersing, promoting the circulation of QI capable stagnant, capture calculus as principle.
At present, the sickness rate of liver, cholelithiasis rises gradually, the treatment of cholelithiasis is adopted to operative therapy more both at home and abroad, but comparatively difficulty of the removal of retained calculus after operation.The medicine that is used for the treatment of liver, gallstone disease and complication thereof in the patent medicine of existing Chinese and Western has: mostly gallbladder health, JINDAN PIAN, Os Gallus domesticus blade, XIAOYAN LIDAN PIAN etc., be that the inflammation that acts on body of gallbladder and biliary tract changes.Through clinical observation, the therapeutic effect of this class medicine is poor, and cure rate is low, can only relief of symptoms and can not cure.
Summary of the invention
In order to make up the deficiencies in the prior art, alleviate liver and bile stone patient's misery, the invention provides a kind of Chinese medicine composition for the treatment of liver and bile stone, it is evident in efficacy, safe and reliable, has wide potential applicability in clinical practice.
Technical scheme of the present invention is:
Treat a Chinese medicine composition for liver and bile stone, this Chinese medicine composition is made up of the raw material of following weight portion: Herba Artemisiae Scopariae 10-12 part, Rhizoma Alismatis 5-8 part, Radix Bupleuri 6-9 part, Rhizoma Coptidis 3-5 part, Rhizoma Chuanxiong 10-12 part, Radix Angelicae Sinensis 10-12 part, Radix Curcumae 3-5 part, Radix Paeoniae Rubra 3-5 part, Radix Salviae Miltiorrhizae 10-12 part, Radix Scutellariae 8-10 part, Endothelium Corneum Gigeriae Galli 6-9 part, Flos Lonicerae 10-12 part, Squama Manis 10-12 part, Rhizoma Corydalis 10-12 part, Radix Glycyrrhizae 12-15 part, Herba Lysimachiae 9-12 part.
In Chinese medicine composition described above, can also contain Radix Aucklandiae 5-8 part and Fructus Crataegi 12-15 part.These two kinds of Chinese medicines can further strengthen analgesic effect and the calculus dissolving and excreting effect of the above-mentioned Chinese medicine composition of the present invention.
Preferably, Chinese medicine composition described above is made up of the raw material of following weight portion: 11 parts of Herba Artemisiae Scopariaes, 7 parts of Rhizoma Alismatis, 7 parts of Radix Bupleuri, 4 parts of Rhizoma Coptidis, 11 parts of Rhizoma Chuanxiongs, 11 parts of Radix Angelicae Sinensis, 4 parts of Radix Curcumaes, 4 parts of Radix Paeoniae Rubra, 11 parts of Radix Salviae Miltiorrhizaes, 9 parts of Radix Scutellariaes, 8 parts of Endothelium Corneum Gigeriae Galli, 11 parts of Flos Loniceraes, 11 parts of Squama Maniss, 11 parts of Rhizoma Corydalis, 13 parts, Radix Glycyrrhizae, 10 parts of Herba Lysimachiaes.More preferably, Chinese medicine composition described above can also contain 13 parts of 6 parts of the Radix Aucklandiae and Fructus Crataegis.
The present invention also asks to protect the purposes of above-mentioned Chinese medicine composition in preparation treatment liver and bile stone medicine.The embodiment of the present invention 7 shows, mice licks foot time response latency and model group comparison, after administration after 1h and 2h, the mice of each administration group of Chinese medicine composition of the present invention licks and is all greater than model group sufficient incubation period of reacting, there is dose-dependence, and be significantly greater than the incubation period of high dose group model group (
p< 0.05).Illustrate Chinese medicine composition of the present invention can extend mice to hot plate stimulate lick the sufficient response latency, have certain analgesic activity.Under same experiment condition, positive control drug has also extended mice and has licked the incubation period that foot reacts, and has certain analgesic activity, but its analgesic effect and model group there was no significant difference.The embodiment of the present invention 8 shows, the each treatment group of Chinese medicine composition of the present invention and positive controls have the effect of Ca, TBIL, DBIL level in remarkable reduction bile and the effect of rising BA level.Wherein low group of the regulating action of positive controls and Chinese medicine of the present invention are approaching.In Chinese medicine of the present invention group and high group compared with positive controls in reduction bile Ca, TBIL, DBIL level and rising BA there is the difference of significance aspect horizontal.
In order to express better Chinese medicine composition of the present invention, Chinese medicine composition of the present invention can be prepared into conventional clinically dosage form.Such as, the preparations such as powderous preparations, powder, pill, sublimed preparation, unguentum, granule, oral liquid, syrup, tablet, capsule, described pharmaceutical preparation all can prepare according to Chinese medicine preparation preparation method well-known to those skilled in the art.Preferably, Chinese medicine composition of the present invention is prepared into powder, water preparation, tablet or capsule according to conventional preparation technology.
The present invention also provides a kind of preparation method of Chinese medicine composition described above, it mainly comprises following step: get the above-mentioned Chinese crude drug of recipe quantity and be broken into coarse powder, doubly adding volumetric concentration according to the 4-9 of coarse powder gross weight is the alcoholic solution of 40%-95%, reflux, extract, three times, return time is 2-5h, filters, filtrate recycling ethanol, cold filtration, washes with water, after being dried, obtains Chinese medical concrete; Those skilled in the art can be at the technical conventional Chinese medicine pharmaceutical dosage form clinically for preparing of this preparation method, as tablet, capsule etc.
The present invention is that inventor is through research repeatedly, progressively improve, last successful a kind of curative effect is treated the medicine of liver and bile stone preferably, for showing the therapeutic effect of medicine of the present invention to liver and bile stone, the liver and bile stone patient that the present invention takes this medicine to 160 examples has carried out clinical observation, and liver and bile stone patient 160 examples of selecting to have a comparability as a control group.Treatment group patient takes medicine twice of the present invention every day, sooner or later respectively once, once takes 5 grams of medicines, and matched group patient takes the oral drugs of conventional therapy liver and bile stone.Treat after one month, therapeutic outcome is in table 1.
Table 1 treatment group and treatment of control group result synopsis
Treatment group is compared matched group and is had higher cure rate and effective percentage, thinks thus, and Drug therapy liver and bile stone of the present invention has good effect, and observes through the treatment of month, takes medicine of the present invention and does not occur any toxic and side effects.
Chinese medicine composition of the present invention, aspect treatment liver and bile stone, compared with prior art has following advantage:
1) compared with the chemotherapeutic agent of current treatment, Chinese medicine composition of the present invention is natural pure Chinese medicinal preparation, and untoward reaction and side effect significantly reduce, and Chinese medicine composition effect of the present invention is comprehensive, medication effect is better, and has improved patient's quality of life;
2) in Chinese medicine composition of the present invention, contain multi-medicament component, action target spot is numerous, compared with positive control drug, pharmaceutical composition Chinese medicine composition of the present invention is more remarkable at lithodialysis, calculus, anti-stone and ease pain, show that the present composition has significant synergism in liver and bile stone treatment, not only can significantly improve the symptom of liver and bile stone, can also delay the development of liver and bile stone, the recovery from illness process that contributes to liver and bile stone patient, has wide potential applicability in clinical practice.
Detailed description of the invention
Further describe the present invention by specific embodiment below, but those skilled in the art should know, described embodiment does not also limit the present invention in any way.
one) example of formulations part
embodiment 1 Chinese medicine composition of the present invention and preparation technology
The weight portion of Chinese medicinal components: 10 parts of Herba Artemisiae Scopariaes, 5 parts of Rhizoma Alismatis, 6 parts of Radix Bupleuri, 3 parts of Rhizoma Coptidis, 10 parts of Rhizoma Chuanxiongs, 10 parts of Radix Angelicae Sinensis, 3 parts of Radix Curcumaes, 3 parts of Radix Paeoniae Rubra, 10 parts of Radix Salviae Miltiorrhizaes, 8 parts of Radix Scutellariaes, 6 parts of Endothelium Corneum Gigeriae Galli, 10 parts of Flos Loniceraes, 10 parts of Squama Maniss, 10 parts of Rhizoma Corydalis, 12 parts, Radix Glycyrrhizae, 9 parts of Herba Lysimachiaes.
Get the above-mentioned Chinese crude drug of recipe quantity and be broken into coarse powder, doubly adding volumetric concentration according to the 4-9 of coarse powder gross weight is the alcoholic solution of 40%-95%, reflux, extract, three times, return time is 2-5h, filters filtrate recycling ethanol, cold filtration, washes with water, after being dried, obtains Chinese medical concrete; Those skilled in the art can be at the technical conventional Chinese medicine pharmaceutical dosage form clinically for preparing of this preparation method, as tablet, capsule etc.
embodiment 2 Chinese medicine composition of the present invention and preparation technology
The weight portion of Chinese medicinal components: 12 parts of Herba Artemisiae Scopariaes, 8 parts of Rhizoma Alismatis, 9 parts of Radix Bupleuri, 5 parts of Rhizoma Coptidis, 12 parts of Rhizoma Chuanxiongs, 12 parts of Radix Angelicae Sinensis, 5 parts of Radix Curcumaes, 5 parts of Radix Paeoniae Rubra, 12 parts of Radix Salviae Miltiorrhizaes, 10 parts of Radix Scutellariaes, 9 parts of Endothelium Corneum Gigeriae Galli, 12 parts of Flos Loniceraes, 12 parts of Squama Maniss, 12 parts of Rhizoma Corydalis, 15 parts, Radix Glycyrrhizae, 12 parts of Herba Lysimachiaes.
Preparation method is with embodiment 1.
embodiment 3 Chinese medicine composition of the present invention and preparation technology
The weight portion of Chinese medicinal components: 11 parts of Herba Artemisiae Scopariaes, 7 parts of Rhizoma Alismatis, 7 parts of Radix Bupleuri, 4 parts of Rhizoma Coptidis, 11 parts of Rhizoma Chuanxiongs, 11 parts of Radix Angelicae Sinensis, 4 parts of Radix Curcumaes, 4 parts of Radix Paeoniae Rubra, 11 parts of Radix Salviae Miltiorrhizaes, 9 parts of Radix Scutellariaes, 8 parts of Endothelium Corneum Gigeriae Galli, 11 parts of Flos Loniceraes, 11 parts of Squama Maniss, 11 parts of Rhizoma Corydalis, 13 parts, Radix Glycyrrhizae, 10 parts of Herba Lysimachiaes.
Preparation method is with embodiment 1.
embodiment 4 Chinese medicine composition of the present invention and preparation technology
The weight portion of Chinese medicinal components: 10 parts of Herba Artemisiae Scopariaes, 5 parts of Rhizoma Alismatis, 6 parts of Radix Bupleuri, 3 parts of Rhizoma Coptidis, 10 parts of Rhizoma Chuanxiongs, 10 parts of Radix Angelicae Sinensis, 3 parts of Radix Curcumaes, 3 parts of Radix Paeoniae Rubra, 10 parts of Radix Salviae Miltiorrhizaes, 8 parts of Radix Scutellariaes, 6 parts of Endothelium Corneum Gigeriae Galli, 10 parts of Flos Loniceraes, 10 parts of Squama Maniss, 10 parts of Rhizoma Corydalis, 12 parts, Radix Glycyrrhizae, 9 parts of Herba Lysimachiaes, 5 parts of the Radix Aucklandiae, 15 parts of Fructus Crataegis.
Preparation method is with embodiment 1.
embodiment 5 Chinese medicine composition of the present invention and preparation technology
The weight portion of Chinese medicinal components: 12 parts of Herba Artemisiae Scopariaes, 8 parts of Rhizoma Alismatis, 9 parts of Radix Bupleuri, 5 parts of Rhizoma Coptidis, 12 parts of Rhizoma Chuanxiongs, 12 parts of Radix Angelicae Sinensis, 5 parts of Radix Curcumaes, 5 parts of Radix Paeoniae Rubra, 12 parts of Radix Salviae Miltiorrhizaes, 10 parts of Radix Scutellariaes, 9 parts of Endothelium Corneum Gigeriae Galli, 12 parts of Flos Loniceraes, 12 parts of Squama Maniss, 12 parts of Rhizoma Corydalis, 15 parts, Radix Glycyrrhizae, 12 parts of Herba Lysimachiaes, 8 parts of the Radix Aucklandiae, 12 parts of Fructus Crataegis.
Preparation method is with embodiment 1.
embodiment 6 Chinese medicine composition of the present invention and preparation technology
The weight portion of Chinese medicinal components: 11 parts of Herba Artemisiae Scopariaes, 7 parts of Rhizoma Alismatis, 7 parts of Radix Bupleuri, 4 parts of Rhizoma Coptidis, 11 parts of Rhizoma Chuanxiongs, 11 parts of Radix Angelicae Sinensis, 4 parts of Radix Curcumaes, 4 parts of Radix Paeoniae Rubra, 11 parts of Radix Salviae Miltiorrhizaes, 9 parts of Radix Scutellariaes, 8 parts of Endothelium Corneum Gigeriae Galli, 11 parts of Flos Loniceraes, 11 parts of Squama Maniss, 11 parts of Rhizoma Corydalis, 13 parts, Radix Glycyrrhizae, 10 parts of Herba Lysimachiaes, 6 parts of the Radix Aucklandiae, 13 parts of Fructus Crataegis.
Preparation method is with embodiment 1.
(2) drug effect embodiment part
the impact of embodiment 7 Chinese medicine composition of the present invention on mice hot-plate analgesia
1 mice hot plate pain model is made
Body weight 20g left and right female mice is placed on hot plate dolorimeter, screen 80 of qualified ♀ mices and (lick metapedes time < 5 s or > 30 s throw aside, scald for preventing foot, also should establish deadline, be generally 60s), be pain valve index the incubation period of licking metapedes reaction taking mice, get 50 jennies, be divided into 5 groups, 10/group, it is model group hydrocortisone group, Chinese medicine composition of the present invention (making by Chinese medicine composition prescription and preparation technology described in embodiment 6) low dose group, middle dosage group and high dose group.Each group is gastric infusion, and 1 times/day, dosage is as shown in table 2, and after successive administration 14d, after mensuration last medicine, 60 min, 120 min lick the time of foot reaction.
2 Chinese medicine compositions of the present invention are on licking the impact of foot response latency in the experiment of mice hot-plate analgesia
Mice licks foot response latency time showing, with model group comparison, after administration, after 1h and 2h, the mice of each administration group of Chinese medicine composition of the present invention licks and is all greater than model group sufficient incubation period of reacting, there is dose-dependence, and be significantly greater than the incubation period of high dose group model group (
p< 0.05).Illustrate this Chinese medicine composition of the present invention can extend mice to hot plate stimulate lick the sufficient response latency, have certain analgesic activity.Under same experiment condition, positive control drug has also extended mice and has licked the incubation period that foot reacts, and has certain analgesic activity, but its analgesic effect and model group there was no significant difference.The results are shown in Table 2.
Table 2 mice lick foot response latency timetable (
)
Note: with model group comparison, *
p< 0.05, * *
p< 0.01
lithodialysis, calculus, the anti-masonry of embodiment 8 the present invention to Cavia porcellus cholesterol calculus model used
1 materials and methods
1.1 laboratory animals: healthy guinea pig is selected in lithodialysis, the experiment of anti-stone, male, body weight 200-300g, totally 100, breed center purchased from Traditional Chinese Medicine University Of Guangzhou's laboratory animal, adopt the mode of raising in cages.
1.2 modeling methods: adopt bait provocation method, normal feedstuff is provided by Traditional Chinese Medicine University Of Guangzhou's experimental animal feeding center, becomes the autogamy of stone feedstuff, formula is Semen Maydis powder 15%, analysis for soybean powder 10%, flour 10%, fish flour 3%, wheat bran 10%, Sal 1%, yeast powder 1%, alfalfa meal 40%, casein 2%, Adeps Sus domestica 2%, sucrose 5%, cholesterol 1%.Normal group is thrown normal diet 11 weeks, and model group is first thrown into stone feedstuff 7 weeks with treatment group of the present invention, after throw normal diet 4 weeks.Prevention group of the present invention is thrown into stone feedstuff 7 weeks.Every day thrown 250g by every cage, and freely drink water (tap water), and feed appropriate Radix Dauci Sativae.
1.3 Experimental agents: the Chinese medicinal composition preparation of the present invention of preparing by embodiment 6.Treatment group is first thrown into stone feedstuff 7 weeks, rear throwing normal diet 4 weeks gastric infusion; Medicine is all used distilled water diluting, gavage gives Chinese medicine of the present invention respectively, high group, middle group, Chinese medicine and low group are respectively containing Chinese medicine composition 2g of the present invention, 1g, 0.5g, every gavage chenodeoxy cholic acid 25mg of positive controls, normal group and model group gavage be with same volume distilled water, at 8 o'clock in the morning every day once daily.
1.4 collection of specimens method animal fasting (can't help water) 24h, lethal from eye socket injection air, cut rapidly breast abdomen open, expose heart, get the about 3ml of cardiac blood with syringe, then expose gallbladder, block cystic duct by vascular forceps, take off gallbladder, first perusal becomes stone situation, and with the whole bile of syringe sucking-off.Bile and blood are placed 40min at normal temperatures, and then the centrifugal 10min of 2000r/pm, gets bile supernatant and serum, be positioned in-20 DEG C of refrigerators, preserve to be measured.
1.5 testing index methods: various index tests all adopt clinical assay reagent box, buy in chemical reagents corporation of Beijing.Wherein T-CHOL and bile acid are enzymic colorimetric; Total bilirubin and bilirubin direct are chemical colorimetry; Calcium ion is sodium ethylene diamine tetracetate method.
1.6 statistical method: this experiment the data obtained utilizes SPSS8.0 statistical software to process, statistical method adopts chi-square analysis and t inspection.
1.7 experimental result
Modelling result: in 10 Cavia porcelluss of model group, 8 form calculus, and this calculus profile is irregular, not of uniform size, and taupe is laminar, and quality is soft, frangible.Model group gallstone formation rate has highly significant difference (P < 0.01) compared with normal group.Chinese medicine composition of the present invention is as shown in table 3 on the impact of every composition in bile.
The impact of table 3 Chinese medicine composition of the present invention on every composition in bile
Note: with normal group comparison,
▲ ▲p < 0.01; With model group comparison
*p < 0.05,
*p < 0.01; With positive controls comparison,
△p < 0.05.
As can be seen from Table 3, the each treatment group of Chinese medicine composition of the present invention and positive controls have the effect of Ca, TBIL, DBIL level in remarkable reduction bile and the effect of rising BA level.Wherein low group of the regulating action of positive controls and Chinese medicine of the present invention are approaching.In Chinese medicine of the present invention group and high group compared with positive controls in reduction bile Ca, TBIL, DBIL level and rising BA there is the difference of significance aspect horizontal.
Claims (7)
1. treat a Chinese medicine composition for liver and bile stone, it is characterized in that being made by the raw material of following weight portion: Herba Artemisiae Scopariae 10-12 part, Rhizoma Alismatis 5-8 part, Radix Bupleuri 6-9 part, Rhizoma Coptidis 3-5 part, Rhizoma Chuanxiong 10-12 part, Radix Angelicae Sinensis 10-12 part, Radix Curcumae 3-5 part, Radix Paeoniae Rubra 3-5 part, Radix Salviae Miltiorrhizae 10-12 part, Radix Scutellariae 8-10 part, Endothelium Corneum Gigeriae Galli 6-9 part, Flos Lonicerae 10-12 part, Squama Manis 10-12 part, Rhizoma Corydalis 10-12 part, Radix Glycyrrhizae 12-15 part, Herba Lysimachiae 9-12 part.
2. the Chinese medicine composition for the treatment of liver and bile stone as claimed in claim 1, is characterized in that: described Chinese medicine composition also contains Radix Aucklandiae 5-8 part and Fructus Crataegi 12-15 part.
3. the Chinese medicine composition for the treatment of liver and bile stone as claimed in claim 1, is characterized in that being made up of the raw material of following weight portion: 11 parts of Herba Artemisiae Scopariaes, 7 parts of Rhizoma Alismatis, 7 parts of Radix Bupleuri, 4 parts of Rhizoma Coptidis, 11 parts of Rhizoma Chuanxiongs, 11 parts of Radix Angelicae Sinensis, 4 parts of Radix Curcumaes, 4 parts of Radix Paeoniae Rubra, 11 parts of Radix Salviae Miltiorrhizaes, 9 parts of Radix Scutellariaes, 8 parts of Endothelium Corneum Gigeriae Galli, 11 parts of Flos Loniceraes, 11 parts of Squama Maniss, 11 parts of Rhizoma Corydalis, 13 parts, Radix Glycyrrhizae, 10 parts of Herba Lysimachiaes.
4. the Chinese medicine composition for the treatment of liver and bile stone as claimed in claim 3, is characterized in that: described Chinese medicine composition also contains 13 parts of 6 parts of the Radix Aucklandiae and Fructus Crataegis.
5. the Chinese medicine composition of the treatment liver and bile stone as described in as arbitrary in claim 1-4, is characterized in that: described Chinese medicine composition is powder, water preparation, tablet or capsule.
6. the Chinese medicine composition for the treatment of liver and bile stone as claimed in claim 5, the preparation method that it is characterized in that described Chinese medicine composition comprises following step: get the above-mentioned Chinese crude drug of recipe quantity and be broken into coarse powder, doubly adding volumetric concentration according to the 4-9 of coarse powder gross weight is the alcoholic solution of 40%-95%, reflux, extract, three times, return time is 2-5h, filters, filtrate recycling ethanol, cold filtration, washes with water, after being dried, obtains Chinese medical concrete; Those skilled in the art can be at the technical conventional Chinese medicine pharmaceutical dosage form clinically for preparing of this preparation method, as tablet, capsule.
7. the purposes of the arbitrary described Chinese medicine composition of claim 1-4 in preparation treatment liver and bile stone medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410272554.7A CN104043042A (en) | 2014-06-18 | 2014-06-18 | Traditional Chinese medicine composition for treating hepatic calculus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410272554.7A CN104043042A (en) | 2014-06-18 | 2014-06-18 | Traditional Chinese medicine composition for treating hepatic calculus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104043042A true CN104043042A (en) | 2014-09-17 |
Family
ID=51496765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410272554.7A Pending CN104043042A (en) | 2014-06-18 | 2014-06-18 | Traditional Chinese medicine composition for treating hepatic calculus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104043042A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104435739A (en) * | 2014-12-24 | 2015-03-25 | 张冬 | Traditional Chinese medicine preparation for treating hepatobiliary lithiasis and preparation method thereof |
| CN106421002A (en) * | 2016-12-13 | 2017-02-22 | 四川西奈生物科技有限公司 | Composition of external ointment beneficial to discharge of hepatic calculus and preparation method thereof |
| CN109430564A (en) * | 2018-12-29 | 2019-03-08 | 广西壮族自治区林业科学研究院 | A kind of Manis javanica special feed and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1751734A (en) * | 2005-09-13 | 2006-03-29 | 郭德润 | Traditional Chinese medicine prepn. for treating lithiasis and its prepn. method |
| CN101850086A (en) * | 2009-11-05 | 2010-10-06 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicinal composition for treating symptom of gallstones and preparation method thereof |
-
2014
- 2014-06-18 CN CN201410272554.7A patent/CN104043042A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1751734A (en) * | 2005-09-13 | 2006-03-29 | 郭德润 | Traditional Chinese medicine prepn. for treating lithiasis and its prepn. method |
| CN101850086A (en) * | 2009-11-05 | 2010-10-06 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicinal composition for treating symptom of gallstones and preparation method thereof |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104435739A (en) * | 2014-12-24 | 2015-03-25 | 张冬 | Traditional Chinese medicine preparation for treating hepatobiliary lithiasis and preparation method thereof |
| CN106421002A (en) * | 2016-12-13 | 2017-02-22 | 四川西奈生物科技有限公司 | Composition of external ointment beneficial to discharge of hepatic calculus and preparation method thereof |
| CN109430564A (en) * | 2018-12-29 | 2019-03-08 | 广西壮族自治区林业科学研究院 | A kind of Manis javanica special feed and preparation method thereof |
| CN109430564B (en) * | 2018-12-29 | 2022-05-24 | 广西壮族自治区林业科学研究院 | Special feed for manis pentadactyla and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103830577B (en) | A kind of medical composition and its use treating hepatobiliary calculus and urinary stone disease | |
| CN102240318A (en) | Traditional Chinese medicine for tonifying qi and increasing breast milk | |
| CN105727145A (en) | Traditional Chinese medicine drug for treating spleen deficiency phlegm-dampness syndrome type hyperlipidaemia | |
| CN101002929A (en) | Medicine for treating functional hypopepsia or complicating Helicobacter pylori infection, and its preparing method | |
| CN104043042A (en) | Traditional Chinese medicine composition for treating hepatic calculus | |
| CN103705796B (en) | A kind of pharmaceutical composition for the treatment of diarrhoea and preparation method thereof | |
| CN104606494A (en) | Traditional Chinese medicine for treating liver cancer and preparation method thereof | |
| CN104491797A (en) | Use of traditional Chinese medicine preparation in preparation of drug for treating intestinal parasites | |
| CN103585583B (en) | Traditional Chinese medicine composition for treating hepatic calculus and application thereof | |
| CN104547961B (en) | A kind of Chinese medicine composition for treating gall stone | |
| CN104548016A (en) | Application of traditional Chinese medicine composition in preparation of medicine for treating hyperuricemia | |
| CN104888157A (en) | Traditional Chinese medicine preparation for treating hysteromyoma and preparation method thereof | |
| CN104474112A (en) | Traditional Chinese medicine for treating urinary calculus and preparation method of traditional Chinese medicine | |
| CN104147268B (en) | Traditional Chinese medicine composition and preparation thereof for treating hepatic and gallbladder calculus | |
| CN104352629B (en) | Traditional Chinese medicine composition for curing calculus of liver and gallbladder and application thereof | |
| CN104352797A (en) | Traditional Chinese medicine for treating advanced lung cancer and application of traditional Chinese medicine | |
| CN1047948C (en) | Oral natural drug composition for curing hysteromyoma | |
| CN115089674B (en) | Traditional Chinese medicine composition for preventing and treating gout by melting urate calculi, and preparation method and application thereof | |
| CN112656867B (en) | Traditional Chinese medicine composition for treating abnormal uterine bleeding and preparation method thereof | |
| CN105535408A (en) | Pharmaceutical composition for treating cholesterol calculus and purpose thereof | |
| CN107007652A (en) | Purposes of the Kangfuxin Liquid Combined with Chinese Herbal in the medicine for preparing treatment infertility | |
| CN105853796A (en) | Medicine composition for treating habitual abortion | |
| CN104491490A (en) | Traditional Chinese medicine preparation for treating liver cancer and preparation method thereof | |
| CN105288344A (en) | Traditional Chinese medicinal composition for treating liver and gall calculi, and application thereof | |
| CN104940518A (en) | Traditional Chinese medicine composition for treating senile intractable constipation, and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140917 |